Intravitreal injections: A review of the evidence for best practice

Clinical and Experimental Ophthalmology

Volumn 41, Issue 5, 2013, Pages 500-507

  Fagan, Xavier J ^a   Al Qureshi, Salmaan ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Endophthalmitis; Intravitreal injection

Indexed keywords

ANESTHETIC AGENT; ANTIBIOTIC AGENT; BEVACIZUMAB; CHLORHEXIDINE; POVIDONE IODINE; RANIBIZUMAB; TRIAMCINOLONE;

AIR CONDITIONING; CLINICAL PRACTICE; ENDOPHTHALMITIS; EYE INFLAMMATION; HAND WASHING; HOSPITAL; HUMAN; INTRAVITREAL DRUG ADMINISTRATION; OPERATING ROOM; OPERATING ROOM PERSONNEL; REVIEW; SURGEON; SURGICAL DRAPE; SURGICAL GLOVE; SURGICAL MASK;

ANESTHETICS, LOCAL; ANGIOGENESIS INHIBITORS; ANTI-BACTERIAL AGENTS; ANTISEPSIS; DISINFECTION; HUMANS; INTRAVITREAL INJECTIONS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY;

EID: 84883281546     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/ceo.12026     Document Type: Review

References (54)

1. Bylsma G, Guymer R, Qureshi S etal. Intravitreous injections. Clin Experiment Ophthalmol 2006; 34: 388-390.
2. Mason JO III, White MF, Feist RM etal. Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection. Retina 2008; 28: 564-567.
3. Bhavsar AR, Googe JM Jr, Stockdale CR etal. Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the Diabetic Retinopathy Clinical Research Network laser-ranibizumab-triamcinolone clinical trials. Arch Ophthalmol 2009; 127: 1581-1583.
4. Rosenfeld PJ, Brown DM, Heier JS etal. Ranibizimuab for age related macular degeneration. N Engl J Med 2006; 344: 1419-1431.
5. NHMRC additional levels of evidence and grades for recommendations for developers of guidelines. Accessed September 2012. Available from: http://www.nhmrc.gov.au/_files_nhmrc/file/guidelines/stage_2_consultation_levels_and_grades.pdf
6. Meyer CH, Mennel S, Eter N. Incidence of endophthalmitis after intravitreal Avastin injection with and without postoperative topical antibiotic application. Ophthalmologe 2007; 104: 952-957. [article in German].
7. Martin DF, Maguire MG, Fine SL etal. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration; two-year results. Ophthalmology 2012; 119: 1388-1398.
8. Cheung CS, Wong AW, Lui A etal. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections. Ophthalmology 2012; 119: 1609-1614.
9. Pilli S, Kotsolis A, Spaide RF etal. Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting. Am J Ophthalmol 2008; 145: 879-882.
10. McCannel CA. Meta-analysis of endophthalmitis after intra-vitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina 2011; 31: 654-661.
11. Moen V, Dahlgren N, Irestedt L. Severe neurological complications after central neuraxial blockades in Sweden 1990-1999. Anesthesiology 2004; 101: 950-959.
12. Lidwell OM, Lowbury EJ, Whyte W. Effect of ultraclean air in operating rooms on deep sepsis in the joint after total hip or knee replacement: a randomised study. Br Med J (Clin Res Ed) 1982; 285: 10-14.
13. Blaha GR, Tilton EP, Barouch FC. Randomized trial of anaesthetic methods for intravitreal injections. Retina 2011; 31: 535-539.
14. Kaderli B, Avci R. Comparison of topical and subconjunctival anaesthesia in intraivitreal injection administrations. Eur J Ophthalmol 2006; 16: 718 - 721.
15. Davis MJ, Pollack JS, Shott S. Comparison of topical anesthetics for intravitreal injections: a randomized clinical trial. Retina 2012; 32: 701-705.
16. Bardocci A, Lofoco G, Peridcaro S etal. Lidocaine 2% gel versus lidocaine 4% unpreserved drops for topical anaesthesia in cataract surgery: a randomized controlled trial. Ophthalmology 2003; 110: 144-149.
17. Boden JH, Myers ML, Lee T etal. Effect of lidocaine gel on povidone-iodine antisepsis and microbial survival. J Cataract Refract Surg 2008; 34: 1773-1775.
18. Doshi RR, Leng T, Fung AE. Povidone-iodine before lidocaine gel anaesthesia achieves surface antisepsis. Ophthalmic Surg Lasers Imaging 2011; 42: 346-349.
19. Prenner JL. Anesthesia for intravitreal injection [Editorial]. Retina 2011; 31: 433-434.
20. Ip MS, Oden NL, Scott IU. SCORE study report 3: study design and baseline characteristics. Ophthalmology 2009; 116: 1770-1777.
21. Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology 1991; 98: 1769-1775.
22. Mino de Kaspar H, Chang RT, Singh K etal. Prospective randomized comparison of 2 different methods of 5% povidone-iodine applications for anterior segment intraocular surgery. Arch Ophthalmol 2005; 123: 161-165.
23. Bucci FA Jr, Amico LM, Guerino A etal. The effect of preop lid scrubs and levofloxacin on eyelid and conjunctival cultures prior to cataract surgery. Invest Ophthalmol Vis Sci 2003; 44: E-Abstract 1446.
24. Maki DG, Ringer M, Alvarado CJ. Prospective randomized trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991; 338: 339-343.
25. Darouiche RO, Wall MJ Jr, Itani KM etal. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med 2010; 362: 18-26.
26. Mac Rae SM, Brown B, Edelhauser HF. The corneal toxicity of presurgical skin antiseptics. Am J Ophthalmol 1984; 97: 221-232.
27. Hamill MB, Osato MS, Wilhelmus KR. Experimental evaluation of chlorhexidine gluconate for ocular antisepsis. Antimicrob Agents Chemother 1994; 26: 793-796.
28. Moss JA, Sanislo SR, Ta CN. A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections. Ophthalmology 2009; 116: 1498-1501.
29. Aas JA, Paster BJ, Stokes LN etal. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 2005; 43: 5721-5732.
30. Doshi RR, Leng T, Fung AE. Reducing oral flora contamination of intravitreal injections with face mask or silence. Retina 2012; 32: 473-476.
31. Wen JC, McCannel CA, Mochon AB etal. Bacterial dispersal associated with speech in the setting of intravitreous injections. Arch Ophthalmol 2011; 129: 1551-1554.
32. Alwrity A, Jackson E, Chen H etal. The use of surgical facemasks during cataract surgery: is it necessary. Br J Ophthalmol 2002; 86: 975-977.
33. Tanner J, Swarbook S, Stuart J. Surgical hand antisepsis to reduce surgical site infection. Cochrane Database Syst Rev 2008; (1): CD004288. DOI: 10.1002/14651858.CD004288.pub2.
34. Girou E, Loyeau S, Legrand P etal. Efficacy of handrubbing with alcohol based solution versus standard handwashing with antiseptic soap: randomized clinical trial. BMJ 2002; 325: 362.
35. Messina MJ, Brodell LA, Brodell RT etal. Hand hygiene in the dermatologist's office: to wash or to rub? J Am Acad Dermatol 2008; 59: 1043-1049.
36. Aiello LP, Brucker AJ, Chang S etal. Evolving guidelines for intravitreous injections. Retina 2004; 24: S3-S19.
37. Shah CP, Garg SJ, Vander JF etal. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmology 2011; 118: 2028-2034.
38. D'Amico DJ, Masonson HN, Patel M etal. Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. Ophthalmology 2006; 113: 992-1001.
39. Brown DM, Kaiser PK, Michels M etal. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006; 355: 1432-1444.
40. Cortez RT, Ramirez G, Collet L etal. Intravitreous bevacizumab injection: an experimental study in New Zealand white rabbits. Arch Ophthalmol 2010; 128: 884-887.
41. Boyer DS, Heier JS, Brown DM. A phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration. Ophthalmology 2009; 116: 1731-1739.
42. Campbell RJ, Bell CM, Paterson JM etal. Stroke rates after introduction of vascular endothelial growth factor inhibitors for macular degeneration: a time series analysis. Ophthalmology 2012; 119: 1604-1608.
43. Martin DF, Maguire MG, Ying GS etal. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 2011; 364: 1897-1908.
44. Moshfeghi DM, Kaiser PK, Scott IU. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2003; 126: 791-796.
45. Elman MJ, Aiello LP, Beck RW etal. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2010; 117: 1064-1077.
46. Bucher RS, Hall E, Reed DM. Effect of intravitreal triamcinolone acetonide on susceptibility to experimental bacterial endophthalmitis and subsequent response to treatment. Arch Ophthalmol 2005; 123: 649-653.
47. Gillies MC, Sutter FK, Simpson JM etal. Intravitreal triamcinolone for refractory diabetic macular oedema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. Ophthalmology 2006; 113: 1533-1538.
48. Ta CN, Egbert PR, Singh K etal. Prospective randomized comparison of 3-day versus 1-hour preoperative ofloxacin prophlaxis for cataract surgery. Ophthalmology 2002; 109: 2036-2040.
49. Moss JM, Sanisol SR, Ta CN. A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections. Ophthalmology 2009; 116: 1498-1501.
50. Groden LR, Murphy B, Rodnite J. Lid flora in blepharitis. Cornea 1991; 10: 50-53.
51. Bannerman TL, Rhoden DL, McAllister SK. The source of coagulase-negative staphylococci in the Endophthalmitis Vitrectomy Study. A comparison of eyelid and intraocular isolates using pulsed-field gel electrophoresis. Arch Ophthalmol 1997; 115: 357-361.
52. Hague RM, Torkildsen GL, Brubaker K. Multicenter open-label study evaluating the efficacy of azithromycin ophthalmic solution 1% on the signs and symptoms of subjects with blepharitis. Cornea 2010; 29: 871-877.
53. Dave SB, Toma HS, Kim SJ. Ophthalmic antibiotic use and multidrug-resistant Staphylococcus epidermidis. Ophthalmology 2011; 118: 2035-2040.
54. Milder E, Vander J, Shah C etal. Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection. Ophthalmology 2012; 119: 1420-1424.